Barclays’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-85,000
Closed -$16.6M 5773
2025
Q3
$16.6M Buy
+85,000
New +$14M ﹤0.01% 1337
2024
Q4
Sell
-3,600
Closed -$189K 5526
2024
Q3
$189K Buy
+3,600
New +$169K ﹤0.01% 4334

Other funds holding ALAB

Barclays's ALAB Position: Q1 2026 in Review

Barclays increased its Astera Labs (ALAB) stake by 35% in Q1 2026, buying an estimated $57.6M and bringing the position to 1,554,180 shares worth $170M. The position accounts for 0.04% of the portfolio, ranked #343.

Barclays first reported a position in ALAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $395M in Q3 2025. 704 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Barclays held 1,554,180 shares of Astera Labs worth $170M as of Q1 2026.
  • Barclays bought 404,100 Astera Labs shares in Q1 2026, an estimated $57.6M.
  • Astera Labs made up 0.04% of Barclays's portfolio in Q1 2026, its #343 holding.
  • Barclays first reported a position in Astera Labs in Q1 2024 and has held it in 9 quarters since.
  • Barclays's Astera Labs position peaked at $395M in Q3 2025.
  • 704 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.